At StemX Bio, we’re transforming drug discovery with our ready-to-use human pancreas microtissue model. Our innovative approach, backed by a patent-pending differentiation protocol, empowers researchers to rapidly advance from screening to clinical trials. Our human microtissue models offer unmatched predictive value, robustness, and scalability, accelerating the development of effective and safer therapies for diabetes. Join us in shaping the future of medical research and treatment.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Leiden, 2317hh, Nl
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://stemxbio.com/
- Keywords
- 3D cell culture, Drug screening, Drug discovery, Islet Biology, 3D in vitro models, Spheroids, Cell-based assays, Drug Development.
- HQ
- Leiden
Stemx Bio Questions
Stemx Bio's website is https://stemxbio.com/
Stemx Bio's LinkedIn profile is https://nl.linkedin.com/company/stemx-bio
Stemx Bio has
2 employees.
View email and phone details for 2
employees at Stemx Bio.
Stemx Bio's industry is
Biotechnology Research
Stemx Bio's top competitors are
Peregrion,
Avigi Therapeutics,
Cantoni Therapeutics,
Plnt Leiden,
Virxcel,
Genlumina,
Fearless League,
Biopartner Leiden,
Knr Biotech,
Leiden Bio Science Park.
Stemx Bio's categories are Biotechnology Research
Stemx Bio's founding year is 2024
